Skip to content
Certara Drug Interaction Solutions
  • About Us
    • What we do
    • How we work
    • Our team
    • History
    • Linked
  • Our Solutions
    • DIDB® – The Drug Interaction Database
    •   Human in vitro datasets
    •   Clinical datasets
    • Custom solutions
    • Testimonials
  • Licensing
    • Does my organization have a DIDB® license?
    • Licensing
    • Account policies
  • News
  • Support
  • Contact Us
  • Sign in
July 31, 2015 |  News

Dr. Ragueneau-Majlessi named UW CoMotion Presidential Innovation Fellow

UW School of Pharmacy Pharmaceutics Clinical Professor Isabelle Ragueneau-Majlessi has been named a UW CoMotion… more…

Post navigation

Organ Impairment-Drug-Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of Drugs
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification
Follow us on Linked

Brochures

  • Why us?
  • Human in vitro drug metabolism
  • Human in vitro drug transporter
  • Clinical drug interaction
  • Clinical organ impairment
  • Clinical pharmacogenetics

News Categories

  • Events
  • New features
  • News
  • Posters
  • Publications

Recent News

  • Data Curation and Entry in DIDB – October Summary
  • DDI Marker Studies Knowledgebase – quarterly update
  • Data Curation and Entry in DIDB – September Summary
  • Mechanistic Studies Supporting the Evaluation of Pharmacokinetic-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2023: a Systemic Review of New Drug Applications
  • Data Curation and Entry in DIDB – August Summary
  • Blog
  • Contact
  • Privacy
Copyright © 2024 Certara, USA. All Rights Reserved.